ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,435Medicare Part D Prescriptions Filled, Including Refills

Rank: 317 out of 6645

$701K Total Retail Price of All Prescriptions

Rank: 638 out of 6645

627 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

25% of this provider’s 627 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 14,050 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 945 875 1 1
ATENOLOL 597 548 2 8
LISINOPRIL 562 533 3 3
METFORMIN HCL 554 525 4 7
OMEPRAZOLE 477 457 5 6
AMLODIPINE BESYLATE 455 419 6 2
HYDROCODONE-ACETAMINOPHEN 447 369 S3 7 5
BENAZEPRIL HCL 377 344 8 21
LEVOTHYROXINE SODIUM 377 338 8 4
HYDROCHLOROTHIAZIDE 369 355 10 9
FUROSEMIDE 340 320 11 11
LOVASTATIN 339 328 12 15
PANTOPRAZOLE SODIUM 258 232 13 29
METOPROLOL TARTRATE 246 229 14 13
ALENDRONATE SODIUM 218 193 15 14
DIOVAN 217 198 16 19
LOSARTAN POTASSIUM 187 186 17 12
ZOLPIDEM TARTRATE 187 160 17 17
WARFARIN SODIUM 178 177 19 16
ATORVASTATIN CALCIUM 178 162 19 10
CARVEDILOL 166 148 21 25
GABAPENTIN 166 155 21 18
METOPROLOL SUCCINATE 165 161 23 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 153 145 24 37
JANUVIA 151 142 25 38
GLIPIZIDE 150 139 26 23
GLIMEPIRIDE 136 110 27 47
DOXAZOSIN MESYLATE 124 121 28 81
INSULIN SYRINGE 124 105 28 61
CLONIDINE HCL 121 99 30 56
FELODIPINE ER 114 105 31 105
TERAZOSIN HCL 111 106 32 48
HUMALOG 111 84 32 137
TAMSULOSIN HCL 111 110 32 22
CLOPIDOGREL 105 104 35 36
RANITIDINE HCL 99 94 36 51
FINASTERIDE 98 98 37 73
GLYBURIDE 98 87 R 37 58
BENAZEPRIL-HYDROCHLOROTHIAZIDE 95 94 39 181
LANTUS 92 86 40 50
PLAVIX 89 89 41 49
HYDRALAZINE HCL 89 81 41 77
CITALOPRAM HBR 82 81 43 35
SPIRONOLACTONE 80 74 44 85
ISOSORBIDE MONONITRATE ER 80 69 44 66
ALLOPURINOL 76 59 46 31
DIGOXIN 72 72 47 59
ACETAMINOPHEN-CODEINE 72 71 S3 47 80
NIFEDIPINE ER 70 55 49 82
LANTUS SOLOSTAR 69 54 50 139
FLUTICASONE PROPIONATE 66 53 51 26
DIOVAN HCT 65 62 52 64
PROAIR HFA 65 52 52 32
CYMBALTA 64 61 54 78
RAMIPRIL 63 63 55 118
GLIPIZIDE ER 63 62 55 239
PEN NEEDLE 61 37 57 159
GEMFIBROZIL 61 57 57 96
IBUPROFEN 61 45 57 42
PREDNISONE 60 55 60 57
ACTOS 60 54 60 71
FAMOTIDINE 57 56 62 33
CYCLOBENZAPRINE HCL 54 41 R 63 157
AMITRIPTYLINE HCL 54 44 R 63 117
OXYBUTYNIN CHLORIDE ER 54 49 63 179
ZETIA 53 47 66 87
PAROXETINE HCL 52 52 67 72
POTASSIUM CHLORIDE 50 48 68 28
PRAVASTATIN SODIUM 50 50 68 20
MIRTAZAPINE 50 50 68 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 3, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.